{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:35:19Z","timestamp":1778801719257,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06126-4","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T19:01:45Z","timestamp":1745953305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Glanzmann thrombasthenia: a multi-center study of demographics, clinical spectrum, and treatment efficacy"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2088-4213","authenticated-orcid":false,"given":"Laila M.","family":"Sherief","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3881-1605","authenticated-orcid":false,"given":"Magdy","family":"El Ekiaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3420-922X","authenticated-orcid":false,"given":"Mahmoud","family":"El-Hawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-1567","authenticated-orcid":false,"given":"Eslam","family":"Elhawary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira A.","family":"Nazim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-3794","authenticated-orcid":false,"given":"Samar M.","family":"Elbahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"4","key":"6126_CR1","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3324\/haematol.2018.214239","volume":"105","author":"JP Botero","year":"2020","unstructured":"Botero JP, Lee K, Branchford BR, Bray PF, Freson K, Lambert MP, Luo M, Mohan S, Ross JE, Bergmeier W et al (2020) Glanzmann thrombasthenia: genetic basis and clinical correlates. Haematologica 105(4):888\u2013894. https:\/\/doi.org\/10.3324\/haematol.2018.214239","journal-title":"Haematologica"},{"key":"6126_CR2","unstructured":"Krause KA, Graham BC (2023) Glanzmann Thrombasthenia. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538270\/"},{"issue":"1","key":"6126_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/joah.joah_68_18","volume":"10","author":"A Tarawah","year":"2019","unstructured":"Tarawah A, Owaidah T, Al-Mulla N, Khanani M, Elhazmi J, Albagshi M, Wali Y, Almohareb S, Almomen A (2019) Management of Glanzmann\u2019s Thrombasthenia-Guidelines based on an expert panel consensus from gulf cooperation council countries. J Appl Hematol 10(1):1\u20139. https:\/\/doi.org\/10.4103\/joah.joah_68_18","journal-title":"J Appl Hematol"},{"issue":"1\u20132","key":"6126_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2009.10.016","volume":"411","author":"M Franchini","year":"2010","unstructured":"Franchini M, Favaloro EJ, Lippi G (2010) Glanzmann thrombasthenia: an update. Clinica Chimica Acta 411(1\u20132):1\u20136. https:\/\/doi.org\/10.1016\/j.cca.2009.10.016","journal-title":"Clinica Chimica Acta"},{"issue":"5","key":"6126_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1586\/ehm.12.46","volume":"5","author":"AT Nurden","year":"2012","unstructured":"Nurden AT, Pillois X, Nurden P (2012) Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment. Expert Rev Hematol 5(5):487\u2013503. https:\/\/doi.org\/10.1586\/ehm.12.46","journal-title":"Expert Rev Hematol"},{"issue":"23","key":"6126_CR6","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1182\/blood-2011-07-365635","volume":"118","author":"AT Nurden","year":"2011","unstructured":"Nurden AT, Fiore M, Nurden P, Pillois X (2011) Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. Blood 118(23):5996\u20136005. https:\/\/doi.org\/10.1182\/blood-2011-07-365635","journal-title":"Blood"},{"key":"6126_CR7","doi-asserted-by":"publisher","unstructured":"Dorgalaleh A, Poon MC, Shiravand Y (2018) Glanzmann thrombasthenia. In: Congenital bleeding disorders: diagnosis and management. Cham: Springer International Publishing, pp 327\u2013355. https:\/\/doi.org\/10.1007\/978-3-319-76723-9","DOI":"10.1007\/978-3-319-76723-9"},{"key":"6126_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2147\/JBM.S273053","volume":"12","author":"A Nurden","year":"2021","unstructured":"Nurden A (2021) Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies? J Blood Medic 12:581\u2013599. https:\/\/doi.org\/10.2147\/JBM.S273053","journal-title":"J Blood Medic"},{"issue":"5","key":"6126_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.4103\/ijmr.IJMR_718_14","volume":"145","author":"D Mutreja","year":"2017","unstructured":"Mutreja D, Sharma RK, Purohit A, Aggarwal M, Saxena R (2017) Evaluation of platelet surface glycoproteins in patients with Glanzmann thrombasthenia: Association with bleeding symptoms. Indian J Med Res 145(5):629\u2013634. https:\/\/doi.org\/10.4103\/ijmr.IJMR_718_14","journal-title":"Indian J Med Res"},{"issue":"8","key":"6126_CR10","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1182\/blood-2004-12-4619","volume":"106","author":"J Fang","year":"2005","unstructured":"Fang J, Hodivala-Dilke K, Johnson BD, Du LM, Hynes RO, White GC, Wilcox DA (2005) Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia. Blood 106(8):2671\u20132679. https:\/\/doi.org\/10.1182\/blood-2004-12-4619","journal-title":"Blood"},{"issue":"10","key":"6126_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/ejhg.2012.151","volume":"20","author":"M Fiore","year":"2012","unstructured":"Fiore M, Nurden AT, Nurden P, Seligsohn U (2012) Clinical utility gene card for: Glanzmann thrombasthenia. Eur J Hum Genet 20(10):1101. https:\/\/doi.org\/10.1038\/ejhg.2012.151","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"6126_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1055\/s-0031-1291380","volume":"37","author":"AT Nurden","year":"2011","unstructured":"Nurden AT, Pillois X, Fiore M, Heilig R, Nurden P (2011) Glanzmann thrombasthenia-like syndromes associated with Macrothrombocytopenias and mutations in the genes encoding the \u03b1IIb\u03b23 integrin. Semin Thromb Hemost 37(6):698\u2013706. https:\/\/doi.org\/10.1055\/s-0031-1291380","journal-title":"Semin Thromb Hemost"},{"key":"6126_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/ejh.ejh_54_21","volume":"47","author":"M Osman","year":"2022","unstructured":"Osman M, Abd El-Azeem H, Afifi O, Abdou M, Elsayh K, Zahran A, Abdelaal A (2022) Evaluation of platelet surface glycoproteins in inherited thrombocytopathy: relationship with bleeding severity. Egypt J Haematol 47:44\u201351. https:\/\/doi.org\/10.4103\/ejh.ejh_54_21","journal-title":"Egypt J Haematol"},{"issue":"5","key":"6126_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3760\/cma.j.issn.0253-2727.2016.05.018","volume":"37","author":"ZY Wang","year":"2016","unstructured":"Wang ZY, Ruan CG (2016) Current state and prospect in treatment of Glanzmann\u2019 s thrombasthenia. Chin J Hematol 37(5):430\u2013431. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2016.05.018","journal-title":"Chin J Hematol"},{"issue":"2","key":"6126_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tmrv.2016.01.001","volume":"30","author":"MC Poon","year":"2016","unstructured":"Poon MC, Di Minno G, d\u2019Oiron R, Zotz R (2016) New Insights Into the Treatment of Glanzmann Thrombasthenia. Transfus Med Rev 30(2):92\u201399. https:\/\/doi.org\/10.1016\/j.tmrv.2016.01.001","journal-title":"Transfus Med Rev"},{"issue":"5\u20136","key":"6126_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000073569","volume":"32","author":"U Seligsohn","year":"2002","unstructured":"Seligsohn U (2002) Glanzmann thrombasthenia: a model disease which paved the way to powerful therapeutic agents. Pathophysiol Haemost Thromb 32(5\u20136):216\u2013217. https:\/\/doi.org\/10.1159\/000073569","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"3","key":"6126_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1055\/s-0040-1718373","volume":"121","author":"MC Poon","year":"2021","unstructured":"Poon MC (2021) The Use of Recombinant Activated Factor VII in Patients with Glanzmann\u2019s Thrombasthenia. Thromb Haemost 121(3):332\u2013340. https:\/\/doi.org\/10.1055\/s-0040-1718373","journal-title":"Thromb Haemost"},{"issue":"6","key":"6126_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00005-017-0454-x","volume":"65","author":"AM Zahran","year":"2017","unstructured":"Zahran AM, Saad K, Elsayh KI, Alblihed MA, Embaby M (2017) Identification of clinicopathological spectrum, platelet glycoprotein IIb\/IIIa complex, and platelet antibodies in Egyptian children with Glanzmann\u2019s thrombasthenia. Arch Immunol Ther Experiment 65(6):565\u2013571. https:\/\/doi.org\/10.1007\/s00005-017-0454-x","journal-title":"Arch Immunol Ther Experiment"},{"issue":"6","key":"6126_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/hae.13844","volume":"25","author":"A Tiede","year":"2019","unstructured":"Tiede A, Giangrande P, Teitel J, Amano K, Benson G, Nemes L, Jimenez-Yuste V, d\u2019Oiron R, El Fegoun SB, Kessler CM (2019) Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement. Haemophilia 25(6):969\u2013978. https:\/\/doi.org\/10.1111\/hae.13844","journal-title":"Haemophilia"},{"issue":"1","key":"6126_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","volume":"5","author":"PD James","year":"2021","unstructured":"James PD, Connell NT, Ameer B, Di Paola J, Eikenboom J, Giraud N, Haberichter S, Jacobs-Pratt V, Konkle B, McLintock C et al (2021) ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv 5(1):280\u2013300. https:\/\/doi.org\/10.1182\/bloodadvances.2020003265","journal-title":"Blood Adv"},{"key":"6126_CR21","doi-asserted-by":"publisher","first-page":"100026","DOI":"10.1016\/j.gpeds.2022.100026","volume":"2","author":"R Mahmood","year":"2022","unstructured":"Mahmood R, Malik HS, Khan M, Ali S, Mahmood A, Khan SA (2022) Glanzmann thrombasthenia\u2014A not so rare platelet function disorder in Pakistan. Global Pediatrics 2:100026. https:\/\/doi.org\/10.1016\/j.gpeds.2022.100026","journal-title":"Global Pediatrics"},{"issue":"3","key":"6126_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/MBC.0000000000001286","volume":"35","author":"TM Belali","year":"2024","unstructured":"Belali TM (2024) Bleeding disorders in Saudi Arabia, causes and prevalence: a review. Blood Coagulat Fibrinolys: Int J Haemostasis Thrombosis 35(3):67\u201372. https:\/\/doi.org\/10.1097\/MBC.0000000000001286","journal-title":"Blood Coagulat Fibrinolys: Int J Haemostasis Thrombosis"},{"key":"6126_CR23","doi-asserted-by":"publisher","unstructured":"Poon MC, Safdari SM (2023) Glanzmann Thrombasthenia: Diagnosis and Management. In: Dorgalaleh A (eds) Congenital Bleeding Disorders. In Springer eBooks (pp. 379\u2013422). https:\/\/doi.org\/10.1007\/978-3-031-43156-2_15","DOI":"10.1007\/978-3-031-43156-2_15"},{"issue":"2","key":"6126_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ajh.20159","volume":"77","author":"G Toogeh","year":"2004","unstructured":"Toogeh G, Sharifian R, Lak M, Safaee R, Artoni A, Peyvandi F (2004) Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran. Am J Hematol 77(2):198\u2013199. https:\/\/doi.org\/10.1002\/ajh.20159","journal-title":"Am J Hematol"},{"issue":"7","key":"6126_CR25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","volume":"75","author":"JN George","year":"1990","unstructured":"George JN, Caen JP, Nurden AT (1990) Glanzmann\u2019s thrombasthenia: the spectrum of clinical disease. Blood 75(7):1383\u20131395","journal-title":"Blood"},{"issue":"6","key":"6126_CR26","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1111\/hae.12017","volume":"18","author":"M Borhany","year":"2012","unstructured":"Borhany M, Fatima H, Naz A, Patel H, Shamsi T (2012) Pattern of bleeding and response to therapy in Glanzmann thrombasthenia. Haemophilia 18(6):e423. https:\/\/doi.org\/10.1111\/hae.12017","journal-title":"Haemophilia"},{"issue":"1","key":"6126_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s43162-024-00317-5","volume":"36","author":"D El Demerdash","year":"2024","unstructured":"El Demerdash D, El Kholy MT, Ayad AA, Tawfik N, Rakha M, Habib SA, El Said MH, Sobhy G, Yacoub M (2024) Rare bleeding disorders in Egyptian females presented with heavy menstrual bleeding: Single-center study. Egypt J Internal Medic 36(1):49. https:\/\/doi.org\/10.1186\/s43162-024-00317-5","journal-title":"Egypt J Internal Medic"},{"issue":"1","key":"6126_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.transci.2018.11.008","volume":"58","author":"D Doherty","year":"2019","unstructured":"Doherty D, Singleton E, Byrne M, Ryan K, O\u2019Connell NM, O\u2019Donnell JS, Lavin M (2019) Missed at first Glanz: Glanzmann thrombasthenia initially misdiagnosed as Von Willebrand Disease. Transfusion Apheres Sci: Off J World Apheresis Assoc: Off J Eur Soc Haemapheresis 58(1):58\u201360. https:\/\/doi.org\/10.1016\/j.transci.2018.11.008","journal-title":"Transfusion Apheres Sci: Off J World Apheresis Assoc: Off J Eur Soc Haemapheresis"},{"key":"6126_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/JBM.S271744","volume":"12","author":"N Mathews","year":"2021","unstructured":"Mathews N, Rivard GE, Bonnefoy A (2021) Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies. J Blood Med 12:449\u2013463. https:\/\/doi.org\/10.2147\/JBM.S271744","journal-title":"J Blood Med"},{"issue":"5","key":"6126_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/09537104.2011.556275","volume":"22","author":"A Farsinejad","year":"2011","unstructured":"Farsinejad A, Abolghasemi H, Kazemi A, Aghaiipour M, Hadjati E, Faranoush M, Jazebi M, Ala F (2011) Classification of Iranian patients with Glanzmann\u2019s Thrombasthenia using a flow cytometric method. Platelets 22(5):321\u2013327. https:\/\/doi.org\/10.3109\/09537104.2011.556275","journal-title":"Platelets"},{"key":"6126_CR31","unstructured":"Farsinejad, A., Abolghasemi, H., Kazemi, A., Aghaee pour M, Faranoush M, Goftar MN, Hajati E, Jazebi M, Ala F (2010). Density of platelet GPIIb-IIIa and bleeding severity in Iranian patients with Glanzmann\u2019s thrombasthenia. Iranian Journal of Blood Cancer, 3(4), 115\u2013121."},{"key":"6126_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-1172-1-10","volume":"1","author":"AT Nurden","year":"2006","unstructured":"Nurden AT (2006) Glanzmann thrombasthenia. Orphanet J Rare Dis 1:10. https:\/\/doi.org\/10.1186\/1750-1172-1-10","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"6126_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/humu.22776","volume":"36","author":"AT Nurden","year":"2015","unstructured":"Nurden AT, Pillois X, Fiore M, Alessi MC, Bonduel M, Dreyfus M, Goudemand J, Gruel Y, Benabdallah-Guerida S, Latger-Cannard V et al (2015) Expanding the Mutation Spectrum Affecting \u03b1IIb\u03b23 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort. Hum Mutat 36(5):548\u2013561. https:\/\/doi.org\/10.1002\/humu.22776","journal-title":"Hum Mutat"},{"issue":"3","key":"6126_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s0268-960x(02)00030-9","volume":"16","author":"S Bellucci","year":"2002","unstructured":"Bellucci S, Caen J (2002) Molecular basis of Glanzmann\u2019s Thrombasthenia and current strategies in treatment. Blood Rev 16(3):193\u2013202. https:\/\/doi.org\/10.1016\/s0268-960x(02)00030-9","journal-title":"Blood Rev"},{"issue":"1","key":"6126_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/joah.joah_68_18","volume":"10","author":"A Tarawah","year":"2019","unstructured":"Tarawah A, Owaidah T, Al-Mulla N, Khanani MF, Elhazmi J, Albagshi M, Wali Y, AlMohareb S, Almomen A (2019) Management of Glanzmann\u2019s Thrombasthenia\u2014Guidelines based on an expert panel consensus from Gulf Cooperation Council countries. J Appl Hematolo 10(1):1\u20139. https:\/\/doi.org\/10.4103\/joah.joah_68_18","journal-title":"J Appl Hematolo"},{"issue":"3","key":"6126_CR36","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1055\/s-0039-1696657","volume":"3","author":"RB Zotz","year":"2019","unstructured":"Zotz RB, Poon MC, Di Minno G, D\u2019Oiron R, Investigators GTR (2019) The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes. TH Open: Companion J Thrombosis Haemostasis 3(3):e286\u2013e294. https:\/\/doi.org\/10.1055\/s-0039-1696657","journal-title":"TH Open: Companion J Thrombosis Haemostasis"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06126-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06126-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T20:03:21Z","timestamp":1746907401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06126-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["6126"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06126-4","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the 1964 Declaration of Helsinki and its subsequent amendments and received approval from the Research Ethics Committee at the Faculty of Medicine, Benha University (MoHP No: 0018122017\/Certificate No: 1017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from parents\/guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}